Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,276 | $4.4 | $84,814 | 1,164,009 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,588 | $4.4 | $6,987 | 139,354 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
15,922 | $4.4 | $70,057 | 1,049,850 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-07 4:32 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
416,667 | $6 | $2,500,002 | 73,805,331 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,741 | $3.07 | $5,345 | 140,942 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
17,392 | $3.07 | $53,393 | 1,065,772 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
21,053 | $3.07 | $64,633 | 1,183,285 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:01 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,652 | $3.71 | $6,129 | 142,683 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,530 | $3.71 | $61,326 | 1,083,164 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
20,009 | $3.71 | $74,233 | 1,204,338 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:08 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
20,455 | $4.33 | $88,570 | 1,224,347 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:02 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,686 | $4.33 | $7,300 | 144,335 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:01 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,896 | $4.33 | $73,160 | 1,099,694 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,635 | $4.34 | $7,096 | 146,021 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,855 | $4.34 | $86,171 | 1,244,802 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,402 | $4.34 | $71,185 | 1,116,590 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
139,791 | $3.7 | $517,227 | 1,264,657 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
136,421 | $3.7 | $504,758 | 1,132,992 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
12,127 | $3.7 | $44,870 | 147,656 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
703 | $3.84 | $2,700 | 159,783 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
5,107 | $3.84 | $19,611 | 1,269,413 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
8,509 | $3.84 | $32,675 | 1,404,448 (Direct) |
View |
| 2022-04-22 Purchase |
2022-04-26 06:48 am |
Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner |
40,285 | $3.8464 | $154,954 | 98,849,443 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 6:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
19,336 | $4.84 | $93,586 | 1,274,520 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-31 Option Award |
2022-11-02 5:57 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
3,404 | $0 | 57,327 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
123,992 | $0 | 89,749,109 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
123,992 | $0 | 129,517,809 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
118,897 | $0 | 122,820 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
123,992 | $0 | 127,215 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | Lo Andrew Director |
123,992 | $0 | 123,992 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-25 06:06 am |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
3,923 | $0 | 3,923 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-25 06:06 am |
N/A 2032-07-19 |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
186,916 | $0 | 186,916 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-25 06:05 am |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
3,223 | $0 | 3,223 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:31 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:29 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:27 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:26 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:25 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-03-30 Tax Withholding |
2022-04-01 6:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
15,092 | $4.74 | 1,274,520 (Direct) |
View |